Reduction of plasma mycophenolic acid (MPA) and its glucuronide (MPAG) concentrations with antibiotic treatment.

被引：6
|
作者：
Naderer, OJ [1 ]
Dupuis, RE [1 ]
Wiwattanawongsa, K [1 ]
Campbell, BJ [1 ]
Hege, SG [1 ]
Smith, PC [1 ]
Johnson, MW [1 ]
机构：
[1] UNCCH, Chapel Hill, NC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80168-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII50
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [1] Concentration of total mycophenolic acid (MPA), mycophenolic acid glucuronide (MPAG) and unbound MPA in diabetic kidney transplant recipients.
    Akhlaghi, F
    Patel, CG
    Zuinga, P
    Lin, S
    Yango, A
    Gohh, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 232 - 232
  • [2] Simultaneous Population Pharmacokinetic Analysis of Unbound Mycophenolic Acid ( MPA), total MPA, and its MPAG and Acyl-MPAG Metabolites
    Okour, Malek
    Jacobson, Pamala
    Brundage, Richard
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S56 - S56
  • [3] Pharmacokinetic analysis of mycophenolic acid (MPA), free MPA and MPA-glucuronide (MPAG) in pediatric renal transplant recipients - A multicenter study.
    Tonshoff, B
    Weber, L
    Armstrong, VW
    Lamersdorf, T
    Andreeva, M
    Niedmann, PD
    Schutz, E
    Wiesel, M
    Mandelbaum, A
    Zimmerhackl, LB
    Mehls, O
    Oellerich, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3282 - A3282
  • [4] DETERMINATION OF MYCOPHENOLIC ACID AND ITS GLUCURONIDE METABOLITE IN PLASMA
    BOPP, RJ
    SCHIRMER, RE
    MEYERS, DB
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (11) : 1750 - +
  • [5] Stability of mycophenolic acid and mycophenolic acid glucuronide in human plasma
    Shipkova, M
    Armstrong, VW
    Schneider, T
    Niedmann, PD
    Schütz, E
    Wieland, E
    Oellerich, M
    CLINICAL CHEMISTRY, 1999, 45 (01) : 127 - 129
  • [6] Relationship between plasma concentrations of mycophenolic acid (MPA) and its acyl glucuronide (AcMPAG) and intestinal damage in Wistar rats treated with mycophenolate mofetil (MMF)
    Shipkova, M
    Voland, A
    Gröne, HJ
    Armstrong, VW
    Oellerich, M
    Wieland, E
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 537 - 537
  • [7] A simplified LC-MS/MS method for the measurement of mycophenolic acid (MPA) and MPAG
    Walsh, Warren
    Banka, Tibor
    Verjee, Zulfikarali
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 510 - 510
  • [8] Relationship between plasma mycophenolic acid and its glucuronide concentrations, and adverse effects in renal transplant patients
    Naito, T
    Uchida, S
    Shinno, K
    Miyamoto, Y
    Takayama, T
    Suzuki, K
    Ozono, S
    Nakano, M
    Ohashi, K
    Hashimoto, H
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 256P - 256P
  • [9] Determination of mycophenolic acid (MPA) and its acyl and phenol glucuronide metabolits simultaneously in human plasma by a simplified HPLC method
    Chen, Bing
    Zhang, Weixia
    Yu, Zicheng
    Cai, Weimin
    ANALYTICAL LETTERS, 2007, 40 (13) : 2465 - 2475
  • [10] Pharmacokinetics of mycophenolic acid (MEPA) and its glucuronide metabolite (MPAG) in liver Tx in combination therapy with tacrolimus, with or without steroids
    Regazzi, M
    Molinaro, M
    Montagna, M
    Bartoli, A
    Cusato, M
    Arienti, B
    De Simone, A
    Reggiani, P
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 535 - 535
12345